Revance Therapeutics
RVNC
#7445
Rank
C$0.46 B
Marketcap
$4.43
Share price
0.65%
Change (1 day)
-60.97%
Change (1 year)

Revance Therapeutics (RVNC) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : C$0.89 Billion

According to Revance Therapeutics's latest financial reports the company's total liabilities are C$0.89 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Revance Therapeutics - Total liabilities on balance sheet (from 2012 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31C$0.83 B8.18%
2022-12-31C$0.77 B31.01%
2021-12-31C$0.58 B33.69%
2020-12-31C$0.44 B194.19%
2019-12-31C$0.14 B36.35%
2018-12-31C$0.10 B225.7%
2017-12-31C$33.76 M-7.94%
2016-12-31C$36.67 M17.13%
2015-12-31C$31.3 M67.57%
2014-12-31C$18.68 M-90.26%
2013-12-31C$0.19 B-16.19%
2012-12-31C$0.22 B15.14%
2011-12-31C$0.19 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
C$4.38 M-99.51%๐Ÿ‡บ๐Ÿ‡ธ USA
C$155.17 B 17,211.89%๐Ÿ‡บ๐Ÿ‡ธ USA
C$17.15 B 1,813.93%๐Ÿ‡บ๐Ÿ‡ธ USA